We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
+1.14%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$610M
AUM Growth
+$126M
(+26%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
25.76%
Top 10 Holdings %
Top 10 Hldgs %
65.04%
Holding
54
New
16
Increased
19
Reduced
10
Closed
8
Top Buys
| 1 |
Boston Scientific
BSX
|
+$46.8M |
| 2 |
GeneDx Holdings
WGS
|
+$42.7M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$20M |
| 4 |
Alkermes
ALKS
|
+$15.9M |
| 5 |
Procept Biorobotics
PRCT
|
+$15.9M |
Top Sells
| 1 |
Icon
ICLR
|
+$20M |
| 2 |
FOLD
Amicus Therapeutics
FOLD
|
+$16.4M |
| 3 |
SEM
Select Medical
SEM
|
+$15.4M |
| 4 |
Roivant Sciences
ROIV
|
+$11.5M |
| 5 |
Avantor
AVTR
|
+$10.3M |
Sector Composition
| 1 | Healthcare | 99.84% |
| 2 | Industrials | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
OrthoPediatrics
KIDS
$507M
| $4.8M | 0.79% |
302,399
+165,658
| +121% | +$2.89M |
|
27
Immunovant
IMVT
$8.19B
| $4.37M | 0.72% |
175,825
-67,579
| -28% | -$1.75M |
|
28
ICU Medical
ICUI
$3.95B
| $3.55M | 0.58% |
+27,450
| New | +$3.95M |
|
|
TECX
29
Tectonic Therapeutic
TECX
$613M
| $2.47M | 0.4% |
79,872
-155,128
| -66% | -$3.82M |
|
30
Rocket Pharmaceuticals
RCKT
$399M
| $2.45M | 0.4% |
683,856
-60,086
| -8% | -$239K |
|
|
UPB
31
Upstream Bio Inc
UPB
$396M
| $2.17M | 0.36% |
+241,123
| New | +$4.34M |
|
32
Pliant Therapeutics
PLRX
$69.4M
| $2.1M | 0.34% |
1,667,600
+111,856
| +7% | +$141K |
|
33
Omeros
OMER
$751M
| $1.85M | 0.3% |
+174,800
| New | +$2.06M |
|
34
Intuitive Surgical
ISRG
$138B
| $1.84M | 0.3% |
+4,000
| New | +$2.02M |
|
35
AN2 Therapeutics
ANTX
$168M
| $1.76M | 0.29% |
+515,754
| New | +$1.06M |
|
36
Adicet Bio
ACET
$81.1M
| $1.7M | 0.28% |
250,244
| – | – |
|
37
Regenxbio
RGNX
$634M
| $1.68M | 0.27% |
+200,000
| New | +$2.1M |
|
38
Coya Therapeutics
COYA
$114M
| $1.66M | 0.27% |
+420,360
| New | +$1.97M |
|
39
Viking Therapeutics
VKTX
$4.39B
| $1.46M | 0.24% |
+45,000
| New | +$1.45M |
|
40
iRhythm Holdings
IRTC
$3.72B
| $1.18M | 0.19% |
+10,000
| New | +$1.44M |
|
|
TBI
41
Trueblue
TBI
$247M
| $974K | 0.16% |
249,107
-193,447
| -44% | -$859K |
|
42
Immuneering
IMRX
$334M
| $650K | 0.11% |
+123,409
| New | +$633K |
|
|
PVLA
43
Palvella Therapeutics
PVLA
$2.18B
| $623K | 0.1% |
+5,000
| New | +$522K |
|
44
NovoCure
NVCR
$1.86B
| $549K | 0.09% |
+50,400
| New | +$629K |
|
|
RNTX
45
Rein Therapeutics
RNTX
$80.9M
| $535K | 0.09% |
411,600
-31,000
| -7% | -$38.5K |
|
46
Transmedics
TMDX
$2.61B
| $497K | 0.08% |
+5,000
| New | +$652K |
|
|
47
Avantor
AVTR
$7.65B
| – | – |
-898,499
| Closed | -$10.3M |
|
48
BridgeBio Pharma
BBIO
$16.2B
| – | – |
-30,000
| Closed | -$2.29M |
|
49
CareDx
CDNA
$1.54B
| – | – |
-250,000
| Closed | -$4.71M |
|
|
FOLD
50
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-1,150,000
| Closed | -$16.4M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA